Author:
Meyer-Monard S,Mühlematter D,Streit A,Chase A J,Gratwohl A,Cross N C P,Jotterand M,Tichelli A
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference7 articles.
1. Wadleigh M, Deangelo DJ, Griffin JD, Stone RM . After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies. Blood 2005; 105: 22–30 (Epub 2004 September 09).
2. Hannemann JR, McManus DM, Kabarowski JH, Wiedemann LM . Haemopoietic transformation by the TEL/ABL oncogene. Br J Haematol 1998; 102: 475–485.
3. Andreasson P, Johansson B, Carlsson M, Jarlsfelt I, Fioretos T, Mitelman F et al. BCR/ABL-negative chronic myeloid leukemia with ETV6/ABL fusion. Genes Chromosomes Cancer 1997; 20: 299–304.
4. Barbouti A, Ahlgren T, Johansson B, Hoglund M, Lassen C, Turesson I et al. Clinical and genetic studies of ETV6/ABL1-positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate. Br J Haematol 2003; 122: 85–93.
5. La Starza R, Trubia M, Testoni N, Ottaviani E, Belloni E, Crescenzi B et al. Clonal eosinophils are a morphologic hallmark of ETV6/ABL1 positive acute myeloid leukemia. Haematologica 2002; 87: 789–794.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献